CRT 2024

CARDIOTUBE INTERVIEW - LATE BREAKING CLINICAL TRIAL: Cost-Effectiveness of Transcatheter Aortic Valve Replacement for Low-Risk Patients – Updated Results from the Evolut Low Risk Trial

Interviewer(s)

• 

  Giorgio A. Medranda, MD

  Structural Interventional Cardiologist
  NYU Langone Hospital - Long Island
  Glen Cove, New York, United States

  No relationships to disclose

Interviewee(s)

• 

  David J. Cohen, MD, FSCAI

  Director of Clinical and Outcomes Research
  Cardiovascular Research Foundation
  New York, New York, United States

  No relationships to disclose